Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission

Sustained elevation of soluble B- and T- lymphocyte attenuator predicts long-term mortality in patients with bacteremia and sepsis

(2022) Anna Lange et al.   PLoS One

ANCA Status or Clinical Phenotype — What Counts More?

(2021) Martin Windpessl et al.   Current Rheumatology Reports

Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis

(2021) Shunsuke Furuta et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement

(2021) Claudius Speer et al.   MEDICINE

The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity

(2020) Alexandra Schnell et al.   CELL RESEARCH

Proteinase-3-anti-neutrophil cytoplasmic antibodies (PR3-ANCAs) predict relapses in ANCA–associated vasculitis patients after rituximab

(2020) Laura S van Dam et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis

(2019) Mark E. McClure et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells

(2019) Kai Werner et al.   Frontiers in Immunology

Vasculitis associated with immune checkpoint inhibitors—a systematic review

(2018) Anisha Daxini et al.   CLINICAL RHEUMATOLOGY

Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

(2018) Alvise Berti et al.   Arthritis & Rheumatology

Soluble immune checkpoints in cancer: production, function and biological significance

(2018) Daqian Gu et al.   Journal for ImmunoTherapy of Cancer

Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis

(2017) Federico Alberici et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome

(2017) Roos M. van der Vuurst de Vries et al.   JAMA Neurology

Cyclophosphamide treatment regulates the balance of functional/exhausted tumor-specific CD8+ T cells

(2017) Aurélie Hanoteau et al.   OncoImmunology

Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation

(2016) Ana C. Anderson et al.   IMMUNITY

Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis

(2015) M. Hilhorst et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection

(2015) Eoin F. McKinney et al.   NATURE

T cell exhaustion during persistent viral infections

(2015) Shannon M. Kahan et al.   VIROLOGY

Peripheral CD5+ B Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

(2015) Sebastian Unizony et al.   Arthritis & Rheumatology

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

(2014) Loïc Guillevin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

(2013) Kirsten de Groot   ANNALS OF INTERNAL MEDICINE

Soluble CD27-Pool in Humans May Contribute to T Cell Activation and Tumor Immunity

(2013) J. Huang et al.   JOURNAL OF IMMUNOLOGY

Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

(2013) Ulrich Specks et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis

(2012) Paul A Monach et al.   ANNALS OF THE RHEUMATIC DISEASES

Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis

(2011) Paul A. Monach et al.   ARTHRITIS AND RHEUMATISM

PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice

(2011) Taku Okazaki et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Soluble CD27 induces IgG production through activation of antigen-primed B cells

(2011) L. V. P. Dang et al.   JOURNAL OF INTERNAL MEDICINE

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE